JSF Financial’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,102
Closed -$250K 132
2024
Q3
$250K Buy
2,102
+3
+0.1% +$400 0.07% 101
2024
Q2
$300K Buy
2,099
+5
+0.2% +$663 0.09% 93
2024
Q1
$269K Buy
2,094
+137
+7% +$16.3K 0.08% 96
2023
Q4
$202K Buy
+1,957
New +$194K 0.07% 105

Other funds holding NVO

JSF Financial's NVO Position: Q4 2024 in Review

JSF Financial sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 2,102 shares — an estimated $250K sold.

JSF Financial first reported a position in NVO in Q4 2023 and held it in 4 quarters. The position peaked at $300K in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • JSF Financial reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • JSF Financial sold 2,102 Novo Nordisk shares in Q4 2024, an estimated $250K.
  • JSF Financial first reported a position in Novo Nordisk in Q4 2023 and held it in 4 quarters.
  • JSF Financial's Novo Nordisk position peaked at $300K in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on JSF Financial's 13F filing for Q4 2024, filed 29 Jan 2025.